DCI Blog


Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Duke Cancer Institute Authorized To Offer Commercial CAR T-Cell Therapy  

On Jan. 31, Duke Cancer Institute joined a select group of medical centers across the country (34 to date) certified and trained to administer Yescarta, the first Food and Drug Administration-approved CAR T-cell therapy for the treatment of adult patients with certain types of relapsed or...

Making Pigs Fly? Investigators Up To The Challenge

When Duke Cancer Institute researcher Christopher Pirozzi, PhD, was an intern doing stem cell research in Australia, he spotted a child’s mobile of a pig with wings in one of the director’s offices. He said it embodied exactly what research meant to him — making the seemingly impossible, possible...

November Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists and researchers whose work was featured in the media and academic journals this month. This list includes Nelson Jen An Chao, MD, MBA, Krista Rowe-Nichols RN, MSN; Allan D. Kirk, MD, PhD; and many more.

Duke Receives $10 Million to Continue Developing Blood-Based Radiation Test

Duke has received a $10.4 million contract from the Biomedical Advanced Research and Development Authority (BARDA), to continue research into the development of a blood test to measure radiation exposure. The test, which is now being developed under the leadership of Nelson Chao, MD, MBA, chief of...